DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Shares of Dentsply Sirona (NASDAQ: XRAY) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share increased 17.54% over the past year to $0.67, which beat the estimate of $0.30.

Recap: Dentsply Sirona Q3 Earnings

Dentsply (XRAY) delivered earnings and revenue surprises of 139.29% and 5.92%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Tops Q3 Earnings and Revenue Estimates

CHARLOTTE, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced its financial results for the three months ended September 30, 2020.

Dentsply Sirona Reports 2020 Third Quarter Results

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dentsply International (XRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

AmerisourceBergen

Align Technology

Becton, Dickinson and Co.

Cardinal Health

Cooper Companies

Henry Schein

Labcorp Holdings Inc

McKesson

Patterson Companies

West Pharmaceutical Services

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

CHARLOTTE, N.C., Oct. 12, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2020 at 8:30 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.

Dentsply Sirona to Host Third Quarter 2020 Conference Call on November 5th

CHARLOTTE, N.C., Sept.  16, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Clyde R. Hosein has been appointed to its Board of Directors (“Board”), increasing the size of its Board from eleven to twelve members.

Dentsply Sirona Announces Appointment of Clyde Hosein as New Board Member

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

Dentsply (XRAY) Up 3.5% Since Last Earnings Report: Can It Continue?

CHARLOTTE, N.C., Sept.  04, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the Baird 2020 Global Healthcare Conference on September 10th.

Dentsply Sirona to Present at the Baird 2020 Global Healthcare Conference

CHARLOTTE, N.C. and BENSHEIM, Germany, Aug. 31, 2020 /PRNewswire/ -- As dental practices adapt to new safety protocols and adjust their workflow practices, Dentsply Sirona continues to develop new solutions for both intraoral and extraoral imaging that produce superior images that support patient satisfaction and practice growth.

Introducing Axeos™ and Schick AE:  Dentsply Sirona's imaging solution for exceptional patient experiences and greater practice success

DENTSPLY (XRAY) continues to gain traction from its solid focus on R&D leading to product innovation, which continues to be a key catalyst.

Here's Why You Should Hold on to DENTSPLY (XRAY) Stock Now

DENTSPLY SIRONA's (XRAY) CEO Don Casey on Q2 2020 Results - Earnings Call Transcript

DENTSPLY SIRONA's (XRAY) second-quarter 2020 results reflect weak segmental performance.

DENTSPLY SIRONA (XRAY) Q2 Earnings & Revenues Miss Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of -500.00% and -3.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Reports Q2 Loss, Lags Revenue Estimates

CHARLOTTE, N.C., Aug.  06, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, announced its financial results for the three months ended June 30, 2020.

Dentsply Sirona Reports Second Quarter 2020 Results

3D Systems

Envista Holdings Corp

Procter & Gamble

SmileDirectClub

Many dentists went out of commission amid the novel coronavirus, but as they open back up, consider these dental stocks to buy. 
The post 7 Dental Stocks to Buy for Long-Term Gains appeared first on InvestorPlace.

7 Dental Stocks to Buy for Long-Term Gains

CHARLOTTE, N.C., July  22, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2020 at 8:00 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.

Dentsply Sirona to Host Second Quarter 2020 Conference Call on August 6th

CHARLOTTE, N.C., June  24, 2020  (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced that on Tuesday, June 23rd, 2020 the United States District Court for the District of New Mexico, in a ruling by Judge Joseph F. Bataillon, held that EdgeTaper Encore endodontic files sold by US Endodontics and Edge Endo infringe at least three valid claims of patents asserted by Dentsply Sirona Inc.  Judge Bataillon granted Dentsply Sirona’s motion for summary judgment that each of the three patent claims were infringed by EdgeTaper Encore and that Dentsply Sirona’s three patent claims are valid.  The Court also rejected Edge’s request to dismiss Dentsply Sirona’s claim that Edge’s infringement was willful.  A finding of willful infringement allows the Court to award treble damages and attorneys’ fees against an adjudicated infringer.

Dentsply Sirona Inc. wins Summary Judgment against Edge Endo and US Endodontics in Patent Infringement Case

Danaher

Medtronic

On 6/25/20, Danaher, DENTSPLY SIRONA and Medtronic will all trade ex-dividend for their respective upcoming dividends.

Ex-Dividend Reminder: Danaher, DENTSPLY SIRONA And Medtronic

Near-Term Outlook Bleak for Medical Dental Supplies Industry

Dentsply (XRAY) Up 22.2% Since Last Earnings Report: Can It Continue?

DENTSPLY SIRONA Inc. (XRAY) CEO Don Casey on Q1 2020 Results - Earnings Call Transcript

Shares of Dentsply Sirona (NASDAQ:XRAY) rose 2% after the company reported Q1 results.

Recap: Dentsply Sirona Q1 Earnings

DENTSPLY SIRONA's (XRAY) first-quarter 2020 preliminary results reflect weak segmental performance and decline in revenues.

DENTSPLY SIRONA (XRAY) Posts Weak Q1 Preliminary Results

Dentsply (XRAY) delivered earnings and revenue surprises of 4.88% and -0.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

News for DENTSPLY SIRONA Stock (XRAY)